drugset / Trial / NCT00410150

Heliox-Powered Albuterol Therapy in the Treatment of Children Admitted With Acute Asthma Exacerbation

NCT00410150 ↗

Phase 2 Terminated 42 enrolled Children's Hospital Medical Center, Cincinnati
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to investigate whether heliox-powered albuterol nebulizer therapy will result in reduced inpatient length of stay in children hospitalized with acute asthma exacerbations.

Timeline

Start
2006-04
Primary completion
2007-12
Completion
2007-12

Outcome

Outcome not reported

Stopped (Enrollment): “Study was stopped after interim analysis and slow enrollment.”

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Oxygen Other / unclassified — —
Background Salbutamol Unknown — Inhaled

Indications